Midostaurin in patients with acute myeloid leukemia and FLT3-TKD mutations: a subanalysis from the RATIFY trial
- Citation:
- Blood Adv vol 4 (19) 4945-4954
- Year:
- 2020
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- Accepted
- Note:
- Pharmas:
- Grants:
- U10CA180821, U24CA196171
- Corr. Author:
- Authors:
- Maria Teresa Voso Richard A. Larson Dan Jones Guido Marcucci Thomas Prior Jürgen Krauter Michael Heuser Serena Lavorgna Josep Nomdedeu Susan M. Geyer Alison Walker Andrew H. Wei Jorge Sierra Miguel A. Sanz Joseph M. Brandwein Theo M. de Witte Joop H. Jansen Dietger Niederwieser Frederick R. Appelbaum Bruno C. Medeiros Martin S. Tallman Richard F. Schlenk Arnold Ganser Sergio Amadori Yuan Cheng YinMiao Chen Celine Pallaud Ling Du Alfonso Piciocchi Gerhard Ehninger John Byrd Christian Thiede Konstanze Döhner Richard M. Stone Hartmut Döhner Clara D. Bloomfield Francesco Lo-Coco
- Networks:
- CA043, GULFSOUTH, LAPS-IL036, LAPS-IL057, LAPS-MA036, LAPS-OH007, OH070
- Study
- CALGB-10603
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords:
- 25, Myeloid Neoplasia